Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 47   

Articles published

TENX 3.40 +0.12 (3.66%)
price chart
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics
MORRISVILLE, N.C., Sep 16, 2014 (BUSINESS WIRE) -- Oxygen Biotherapeutics, Inc. OXBT a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the ...
Beleagured Morrisville drug developer changes name, sharpens focus  Triangle Business Journal
Related articles »  
Tenax Therapeutics Inc Analyst Rating Update
As many as 2 brokerage firms have rated Tenax Therapeutics Inc (NASDAQ:TENX) at 1. Research Analysts at Zacks have ranked the company at 3, suggesting the traders with a rating of Neutral.
Short Interest of Tenax Therapeutics Inc Drops by -7.3%
Tenax Therapeutics Inc (NASDAQ:TENX) stated loss of 108,731 shares or 7.3% in the short interest. The short interest registered from 1,484,137 on December 15,2014 to 1,375,406 on December 31,2014.
Tenax Therapeutics PT Set at $7.00 by MLV & Co  WKRB News
UPDATE: MLV Initiates Coverage On Tenax Therapeutics
The United States Food and Drug Administration recently granted Fast Track status for levosimendan, and Tenax enrolled their first patient in the Phase III study in September.
Stocks Underperform for the Week: Tenax Therapeutics Inc , BioLife Solutions Inc
Tenax Therapeutics Inc (NASDAQ:TENX) has lost 8.02% during the past week and dropped 13.94% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 9.48%.
Tenax Therapeutics' (TENX) CEO John Kelley on Q1 2015 Results - Earnings ...
Greetings and welcome to the Tenax Therapeutics First Quarter 2015 Earnings call. At this time, all participants are in a listen-only mode.
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results  Business Wire (press release)
Related articles »  
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS ...
MORRISVILLE, N.C., Sep 22, 2014 (BUSINESS WIRE) -- Tenax Therapeutics, Inc. TENX, +0.31% formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical ...
Morrisville's Tenax studies experimental drug in cardiac surgery patients  Triangle Business Journal
Related articles »  
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter ...
As a result, RA Capital Management is left holding 8.03 million shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In another move, the fund's manager, Peter Kolchinsky, has initiated a position in Tenax Therapeutics Inc (NASDAQ:TENX). According ...
Related articles »  
Tenax Therapeutics (TENX) Jumps: Stock Moves Up 7.8%
Tenax Therapeutics, Inc. (TENX) was a big mover last session, as its shares rose nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
Related articles »  
Oxygen Biotherapeutics, Inc. (OXBT) news: Oxygen Biotherapeutics surges after ...
Oxygen Biotherapeutics' (OXBT) shares soar 30% after the FDA verbally lifts a hold on clinical trials of the company's Oxycyte treatment for traumatic brain injury (TBI). The FDA's decision comes after Oxygen submitted animal study data in September ...
Related articles »